BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19742143)

  • 1. Diabetes and PET Scans: Only Part of a Bigger Problem.
    Khithani A
    Gastrointest Cancer Res; 2009 Jul; 3(4):165-6. PubMed ID: 19742143
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
    Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
    J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Noise Penalty Factor on Quantification in Bayesian Penalized Likelihood (Q.Clear) Reconstructions of
    Rijnsdorp S; Roef MJ; Arends AJ
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34066854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma.
    Dittmann H; Sokler M; Kollmannsberger C; Dohmen BM; Baumann C; Kopp A; Bares R; Claussen CD; Kanz L; Bokemeyer C
    Oncol Rep; 2001; 8(6):1393-9. PubMed ID: 11605073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of positron emission tomography for the detection of melanoma metastases.
    Holder WD; White RL; Zuger JH; Easton EJ; Greene FL
    Ann Surg; 1998 May; 227(5):764-9; discussion 769-71. PubMed ID: 9605668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of high blood glucose prior to FDG PET.
    Khandani AH; Bravo IM; Patel PS; Ivanovic M; Kirk D
    Abdom Radiol (NY); 2017 May; 42(5):1583-1585. PubMed ID: 27999884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel supervised learning method to generate CT images for attenuation correction in delayed pet scans.
    Rao F; Yang B; Chen YW; Li J; Wang H; Ye H; Wang Y; Zhao K; Zhu W
    Comput Methods Programs Biomed; 2020 Dec; 197():105764. PubMed ID: 33010702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prone mammoPET acquisition improves the ability to fuse MRI and PET breast scans.
    Moy L; Noz ME; Maguire GQ; Ponzo F; Deans AE; Murphy-Walcott AD; Kramer EL
    Clin Nucl Med; 2007 Mar; 32(3):194-8. PubMed ID: 17314593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Diabetes on the Interpretation of PET Scans in Patients With Esophageal Cancer.
    Haley M; Konski A; Li T; Cheng JD; Maurer A; Haluszka O; Scott W; Meropol NJ; Cohen SJ; Freedman G
    Gastrointest Cancer Res; 2009 Jul; 3(4):149-52. PubMed ID: 19742140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of positron emission tomography scans in mantle cell lymphoma.
    Hosein PJ; Pastorini VH; Paes FM; Eber D; Chapman JR; Serafini AN; Alizadeh AA; Lossos IS
    Am J Hematol; 2011 Oct; 86(10):841-5. PubMed ID: 21922524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer.
    Sjövall J; Bitzén U; Kjellén E; Nilsson P; Wahlberg P; Brun E
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):609-16. PubMed ID: 26428529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
    Taghipour M; Sheikhbahaei S; Trahan TJ; Subramaniam RM
    Nucl Med Commun; 2016 Jun; 37(6):602-8. PubMed ID: 27110955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT and lung cancer: value of fourth and subsequent posttherapy follow-up scans for patient management.
    Marcus C; Paidpally V; Antoniou A; Zaheer A; Wahl RL; Subramaniam RM
    J Nucl Med; 2015 Feb; 56(2):204-8. PubMed ID: 25613535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET-CT scans in recurrent or persistent differentiated thyroid cancer: is there added utility beyond conventional imaging?
    Lal G; Fairchild T; Howe JR; Weigel RJ; Sugg SL; Menda Y
    Surgery; 2010 Dec; 148(6):1082-9; discussion 1089-90. PubMed ID: 21134537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans.
    Gispert JD; Pascau J; Reig S; Martínez-Lázaro R; Molina V; García-Barreno P; Desco M
    Neuroimage; 2003 Jul; 19(3):601-12. PubMed ID: 12880791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gradient-based generation of intermediate images for heterogeneous tumor segmentation within hybrid PET/MRI scans.
    Sbei A; ElBedoui K; Barhoumi W; Maktouf C
    Comput Biol Med; 2020 Apr; 119():103669. PubMed ID: 32339115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FDG-PET and Bone Scans for Detecting Skeletal Metastases in Patients with Non-small Cell Lung Cancer.
    Durski JM; Srinivas S; Segall G
    Clin Positron Imaging; 2000 May; 3(3):97-105. PubMed ID: 11008099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans.
    Zasadny KR; Kison PV; Quint LE; Wahl RL
    Radiology; 1996 Dec; 201(3):873-6. PubMed ID: 8939245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
    Hawryluk EB; O'Regan KN; Sheehy N; Guo Y; Dorosario A; Sakellis CG; Jacene HA; Wang LC
    J Am Acad Dermatol; 2013 Apr; 68(4):592-599. PubMed ID: 23127473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.